Literature DB >> 21252449

Epidemiology and risk factors for ESBL-producing Klebsiella pneumoniae: a case control study.

Kutbettin Demirdag1, Salih Hosoglu.   

Abstract

INTRODUCTION: Increased production of extended-spectrum β-lactamases (ESBLs) has become an important issue for treatment of severe Klebsiella pneumoniae (K. pneumoniae) infections. This study aimed to evaluate risk factors of infection from ESBL-producing K. pneumoniae (ESBL-KP).
METHODOLOGY: Risk factors were evaluated using a retrospective case control design. Fifty-two patients admitted to Firat University Hospital (FUH) with invasive infections from ESBL-KP were employed as cases. Patients admitted to FUH with non-ESBL-producing K. pneumoniae invasive infection were chosen as controls. Potential risk factors of the cases and controls were evaluated using hospital charts. Pulsed-field Gel Electrophoresis (PFGE) was used to show the relatedness of ESBL-KP strains.
RESULTS: In univariate analysis, the following factors were found significant for ESBL-KP: pre-infection hospital stay, nosocomial origin, central venous catheterization, surgical intervention, antibiotic use longer than one week, and previous hospitalization. In contrast, stepwise logistic regression analysis showed that two variables, previous antibiotic use (p = 0.000) and surgical intervention (p = 0.006), remained significantly associated with risk for infection with an ESBL-KP. Molecular epidemiology identified several clusters among the ESBL-producing isolates.
CONCLUSIONS: Antibiotic use and surgical intervention were significant associated factors for infections with ESBL-KP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21252449     DOI: 10.3855/jidc.778

Source DB:  PubMed          Journal:  J Infect Dev Ctries        ISSN: 1972-2680            Impact factor:   0.968


  9 in total

1.  Molecular epidemiology of aminoglycosides resistance on Klebsiella pneumonia in a hospital in China.

Authors:  Caiqian Liang; Bangrong Xing; Xiaoyan Yang; Yongmei Fu; Yaqun Feng; Yongbiao Zhang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Utility of a clinical risk factor scoring model in predicting infection with extended-spectrum β-lactamase-producing enterobacteriaceae on hospital admission.

Authors:  Steven W Johnson; Deverick J Anderson; D Byron May; Richard H Drew
Journal:  Infect Control Hosp Epidemiol       Date:  2013-02-14       Impact factor: 3.254

3.  Novel chromosomal insertions of ISEcp1-blaCTX-M-15 and diverse antimicrobial resistance genes in Zambian clinical isolates of Enterobacter cloacae and Escherichia coli.

Authors:  Misheck Shawa; Yoshikazu Furuta; Gillan Mulenga; Maron Mubanga; Evans Mulenga; Tuvshinzaya Zorigt; Christone Kaile; Manyando Simbotwe; Atmika Paudel; Bernard Hang'ombe; Hideaki Higashi
Journal:  Antimicrob Resist Infect Control       Date:  2021-05-10       Impact factor: 4.887

4.  Evaluation of the efficacy of a bacteriophage in the treatment of pneumonia induced by multidrug resistance Klebsiella pneumoniae in mice.

Authors:  Fang Cao; Xitao Wang; Linhui Wang; Zhen Li; Jian Che; Lili Wang; Xiaoyu Li; Zhenhui Cao; Jiancheng Zhang; Liji Jin; Yongping Xu
Journal:  Biomed Res Int       Date:  2015-03-23       Impact factor: 3.411

5.  Antimicrobial susceptibility pattern of extended-spectrum beta- lactamase producing Klebsiella pneumoniae clinical isolates in an Indian tertiary hospital.

Authors:  Amit Kumar Singh; Sonali Jain; Dinesh Kumar; Ravinder Pal Singh; Hitesh Bhatt
Journal:  J Res Pharm Pract       Date:  2015 Jul-Sep

Review 6.  Clinical and Molecular Epidemiology of Extended-Spectrum Beta-Lactamase-Producing Klebsiella spp.: A Systematic Review and Meta-Analyses.

Authors:  Tirza C Hendrik; Anne F Voor In 't Holt; Margreet C Vos
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

7.  Antimicrobial susceptibility and genetic similarity of ESBL-positive Klebsiella pneumoniae strains.

Authors:  Alicja Sękowska; Eugenia Gospodarek; Dorota Kamińska
Journal:  Arch Med Sci       Date:  2012-12-19       Impact factor: 3.318

8.  A multidisciplinary intervention to reduce infections of ESBL- and AmpC-producing, gram-negative bacteria at a University Hospital.

Authors:  Jenny Dahl Knudsen; Stig Ejdrup Andersen
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

Review 9.  Meta-analysis of proportion estimates of Extended-Spectrum-Beta-Lactamase-producing Enterobacteriaceae in East Africa hospitals.

Authors:  Tolbert Sonda; Happiness Kumburu; Marco van Zwetselaar; Michael Alifrangis; Ole Lund; Gibson Kibiki; Frank M Aarestrup
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-14       Impact factor: 4.887

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.